| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |